deltatrials
Unknown OBSERVATIONAL NCT01101295

The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia. (ITP-RITUX)

The ITP-RITUX Cohort: An Observational Study on Rituximab Off-label Use for Immune ThrombocytoPenia.

Sponsor: Henri Mondor University Hospital

Conditions Autoimmune Thrombocytopenia Purpura, Thrombocytopenic, Idiopathic
Updated 8 times since 2017 Last updated: Mar 20, 2012 Started: Apr 30, 2010 Primary completion: Apr 30, 2012 Completion: Apr 30, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Autoimmune Thrombocytopenia and Purpura, Thrombocytopenic, Idiopathic, this trial is ongoing. The trial is conducted by Henri Mondor University Hospital and has accumulated 8 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshotRecruiting~May 2017 – ~Apr 2018 · 11 months · monthly snapshotUnknown Status~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown Status → Unknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status

▶ Show 3 earlier versions

  1. Apr 2018 — Jun 2018 [monthly]

    Unknown Status

    Phase: NA → None

  2. May 2017 — Apr 2018 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

  3. Jan 2017 — May 2017 [monthly]

    Recruiting NA

    First recorded

Apr 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Henri Mondor University Hospital
  • Roche Pharma AG
Data source: Henri Mondor University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations